×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
HAE – haemonetics corporation (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
HAE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
10/3
04:05 pm
hae
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024
Low
Report
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024
9/23
11:08 am
hae
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.
Low
Report
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.
9/20
01:09 am
hae
Is Haemonetics Corporation (HAE) an Undervalued Healthcare Stock to Buy in 2025 [Yahoo! Finance]
Low
Report
Is Haemonetics Corporation (HAE) an Undervalued Healthcare Stock to Buy in 2025 [Yahoo! Finance]
9/13
09:02 am
hae
Haemonetics Co. (NYSE: HAE) is now covered by analysts at CL King. They set a "buy" rating and a $116.00 price target on the stock.
Medium
Report
Haemonetics Co. (NYSE: HAE) is now covered by analysts at CL King. They set a "buy" rating and a $116.00 price target on the stock.
9/11
08:02 am
hae
Haemonetics Co. (NYSE: HAE) is now covered by analysts at Bank of America Co.. They set a "neutral" rating and a $85.00 price target on the stock.
Low
Report
Haemonetics Co. (NYSE: HAE) is now covered by analysts at Bank of America Co.. They set a "neutral" rating and a $85.00 price target on the stock.
9/10
07:59 am
hae
Haemonetics Co. (NYSE: HAE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $112.00 price target on the stock.
Low
Report
Haemonetics Co. (NYSE: HAE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $112.00 price target on the stock.
9/9
10:09 pm
hae
Global Blood Collection Market Size To Worth USD 24.90 Billion By 2033 | CAGR of 8.02% [Yahoo! Finance]
Low
Report
Global Blood Collection Market Size To Worth USD 24.90 Billion By 2033 | CAGR of 8.02% [Yahoo! Finance]
8/28
06:39 pm
hae
Apheresis Market Size to Surge to USD 6.7 Billion by 2034, Driven by Strong Growth Momentum at 7.7% CAGR | Report by Transparency Market Research, Inc. [Yahoo! Finance]
Low
Report
Apheresis Market Size to Surge to USD 6.7 Billion by 2034, Driven by Strong Growth Momentum at 7.7% CAGR | Report by Transparency Market Research, Inc. [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/5
04:17 pm
hae
Form 4 HAEMONETICS CORP For: Nov 01 Filed by: Galvin Roy
Neutral
Report
Form 4 HAEMONETICS CORP For: Nov 01 Filed by: Galvin Roy
9/18
04:19 pm
hae
Form 4 HAEMONETICS CORP For: Sep 17 Filed by: Miller Laurie A.
Low
Report
Form 4 HAEMONETICS CORP For: Sep 17 Filed by: Miller Laurie A.
9/16
04:18 pm
hae
Form 8-K HAEMONETICS CORP For: Sep 10
Low
Report
Form 8-K HAEMONETICS CORP For: Sep 10
9/3
04:21 pm
hae
Form 4 HAEMONETICS CORP For: Aug 29 Filed by: Simon, Christopher
Low
Report
Form 4 HAEMONETICS CORP For: Aug 29 Filed by: Simon, Christopher
8/8
06:06 am
hae
Form 10-Q HAEMONETICS CORP For: Jun 29
High
Report
Form 10-Q HAEMONETICS CORP For: Jun 29
8/8
06:05 am
hae
Form 8-K HAEMONETICS CORP For: Aug 08
High
Report
Form 8-K HAEMONETICS CORP For: Aug 08
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/6
Q1/2020 6/29/2019 EPS 0.810 ZacksConsensus 0.630 ActVsEst 0.180 - Beat
12.0%
2/4 Q3/2020 12/28/2019 EPS 0.940 ZacksConsensus 0.760 ActVsEst 0.180 - Beat 9.5%
4/2 Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic Testing Portfolio 8.9%
11/1 Q2/2020 9/28/2019 EPS 0.870 ZacksConsensus 0.720 ActVsEst 0.150 - Beat 7.2%
2/5 Haemonetics Co. (NYSE: HAE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $142.00 price target on the stock. 7.2%
5/13 Form 5 HAEMONETICS CORP For: Mar 30 Filed by: KROLL MARK W 5.8%
4/13 Form 4 HAEMONETICS CORP For: Apr 09 Filed by: KROLL MARK W 5.1%
4/17 Michael Coyle Joins Haemonetics Board of Directors 4.7%
5/7 Q4/2019 3/30/2019 EPS 0.610 ZacksConsensus 0.550 ActVsEst 0.060 - Beat 4.4%
8/12 Form 4 HAEMONETICS CORP For: Aug 09 Filed by: Goldstein Dan 3.2%
2/4 Q3/2020 12/28/2019 EPS 0.940 ZacksConsensus 0.760 ActVsEst 0.180 - Beat 9.5%
4/2 Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic Testing Portfolio 8.9%
11/1 Q2/2020 9/28/2019 EPS 0.870 ZacksConsensus 0.720 ActVsEst 0.150 - Beat 7.2%
2/5 Haemonetics Co. (NYSE: HAE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $142.00 price target on the stock. 7.2%
5/13 Form 5 HAEMONETICS CORP For: Mar 30 Filed by: KROLL MARK W 5.8%
4/13 Form 4 HAEMONETICS CORP For: Apr 09 Filed by: KROLL MARK W 5.1%
4/17 Michael Coyle Joins Haemonetics Board of Directors 4.7%
5/7 Q4/2019 3/30/2019 EPS 0.610 ZacksConsensus 0.550 ActVsEst 0.060 - Beat 4.4%
8/12 Form 4 HAEMONETICS CORP For: Aug 09 Filed by: Goldstein Dan 3.2%
TOP News Decliners
4/7
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Raymond James from $150.00 to $130.00. They now have an "outperform" rating on the stock.
-8.2%
11/2 Haemonetics (HAE) Q2 2020 Earnings Call Transcript [The Motley Fool] -6.5%
1/23 Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Raymond James from $150.00 to $145.00. They now have an "outperform" rating on the stock. -4.8%
5/22 Form 10-K HAEMONETICS CORP For: Mar 30 -3.3%
3/30 Haemonetics Appoints Anila Lingamneni Executive Vice President, Chief Technology Officer -2.8%
5/11 Haemonetics Corporation (HAE) CEO Chris Simon on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -2.7%
5/24 Form 4 HAEMONETICS CORP For: May 22 Filed by: Simon, Christopher -2.6%
9/3 Form 4 HAEMONETICS CORP For: Aug 30 Filed by: Bolorforosh Said -2.1%
2/4 Form 10-Q HAEMONETICS CORP For: Dec 28 -2.0%
9/9 Form 4 HAEMONETICS CORP For: Sep 05 Filed by: Llorens Josep -1.7%
11/2 Haemonetics (HAE) Q2 2020 Earnings Call Transcript [The Motley Fool] -6.5%
1/23 Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Raymond James from $150.00 to $145.00. They now have an "outperform" rating on the stock. -4.8%
5/22 Form 10-K HAEMONETICS CORP For: Mar 30 -3.3%
3/30 Haemonetics Appoints Anila Lingamneni Executive Vice President, Chief Technology Officer -2.8%
5/11 Haemonetics Corporation (HAE) CEO Chris Simon on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -2.7%
5/24 Form 4 HAEMONETICS CORP For: May 22 Filed by: Simon, Christopher -2.6%
9/3 Form 4 HAEMONETICS CORP For: Aug 30 Filed by: Bolorforosh Said -2.1%
2/4 Form 10-Q HAEMONETICS CORP For: Dec 28 -2.0%
9/9 Form 4 HAEMONETICS CORP For: Sep 05 Filed by: Llorens Josep -1.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: